
Glimozen 1mg/500mg Tablet SR
Marketer
Brzee Mediscience
Salt Composition
Glimepiride (1mg) + Metformin (500mg)
Overview Glimozen 1mg/500mg Tablet SR
Diabetol Duo 1mg/500mg Extended-Release Tablets are classified as antidiabetic agents. This dual-action medication treats type 2 diabetes in adults by regulating blood glucose. Diabetol Duo should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as discontinuation without medical supervision can elevate glucose levels, potentially leading to complications such as nephropathy, retinopathy, neuropathy, and peripheral vascular disease. This medication is one component of a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle modifications are vital for effective diabetes control. The most prevalent adverse effect is hypoglycemia (low blood sugar). Learn to identify symptoms like sweating, lightheadedness, headache, and tremors, and know how to manage them. Consistent meals and readily available fast-acting glucose sources (e.g., sugary snacks, fruit juice) are essential preventative measures. Alcohol consumption increases hypoglycemia risk and should be minimized. Other potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain may also occur. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Individuals with a history of cardiovascular disease should inform their physician before commencing treatment. Pregnant or lactating women should consult their doctor prior to use. Regular blood glucose monitoring, along with periodic blood tests to assess blood cell counts and liver function, are recommended.
Uses of Glimozen 1mg/500mg Tablet SR
Managing Type 2 Diabetes
Major Benefits of Glimozen 1mg/500mg Tablet SR:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the Glimozen 1mg/500mg Tablet SR whole; avoid chewing, crushing, or breaking it. Consume this medication with food.
Common Side effects of Glimozen 1mg/500mg Tablet SR:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Glimozen 1mg/500mg Tablet SR:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the entire tablet without chewing, crushing, or fracturing it. The Glimozen 1mg/500mg sustained-release tablet should be administered with a meal.
How Glimozen 1mg/500mg Tablet SR works:
Glimozen SR tablets (1mg/500mg) combine glimepiride and metformin, two agents used to manage diabetes. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts through multiple mechanisms: decreasing hepatic glucose production, retarding intestinal glucose uptake, and enhancing insulin responsiveness.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glimozen 1mg/500mg SR tablets with alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
The use of Glimozen 1mg/500mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingUNSAFE
Extended-release Glimozen tablets (1mg/500mg) are contraindicated for breastfeeding mothers due to potential infant toxicity.
DrivingCAUTION
Impaired driving is possible with both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Glimozen 1mg/500mg SR tablets, as dosage modification may be necessary. Medical supervision is recommended. Glimozen 1mg/500mg SR tablets are contraindicated in individuals with severe kidney disease. Close monitoring of renal function is advised during treatment.
LiverCAUTION
Exercise caution when administering Glimozen 1mg/500mg SR tablets to individuals with hepatic impairment. Dosage modification of Glimozen 1mg/500mg SR tablets may be necessary. Physician consultation is advised. For patients experiencing mild to moderate liver dysfunction, initiate Glimozen 1mg/500mg SR therapy with a reduced starting dose; however, its use is contraindicated in cases of severe liver disease.
What if you forget to take Glimozen 1mg/500mg Tablet SR :
Should you forget a dose of Glimozen 1mg/500mg Extended-Release Tablet, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glimozen 1mg/500mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes medication |
